Controversy Surrounding New Female Viagra Essay

Open, View, and/or
Download this Document

Total Length: 700 words ( 2 double-spaced pages)

Total Sources: 3

Page 1 of 2

A controversial drug geared towards enhancing female sexual desire was approved by the United States Food and Drug Administration after being rejected twice. The drug, which is known as flibranserin, was produced by Sprout Pharmaceuticals and is geared towards treatment of low sexual desire in women. The company manufactured the drug on the premise that low sexual desire in women has seemingly been ignored while there are 24 drugs for men for either erectile dysfunction or testosterone replacement (Thacker, 2014). However, the drug has remained controversial and attracted divergent opinions, especially with regards to its potential risks and benefits. As a result, providing recommendation to potential patients inquiring about the drug requires a critical evaluation of these arguments as well as potential risks and benefits based on scientific evidence.

Main Points from Both Sides of the Argument

One of the major arguments that has been used to support the drug is the fact that low sexual desire in women has been ignored by the medical field while men have a variety of drugs for treatment of erectile dysfunction or testosterone replacement. Currently, there are no drugs for common sexual dysfunction forms in women, which makes flibranserin a necessity. Secondly, proponents support the drug on the basis of its potential impact in treating hypoactive sexual desire disorder (HSDD), a common sexual dysfunction condition in women.

Stuck Writing Your "Controversy Surrounding New Female Viagra" Essay?

View All Our Example Controversy Surrounding New Female Viagra Essay

Have A Custom Example Essay Written

They argue that the drug has the potential to jolt neurotransmitters to revive the flagging flames of sexual desire in a woman (Schulte, 2015).

However, those opposed to the drug argue that hypoactive sexual desire disorder (HSDD) is a creation of the drug industry. They state that low sexual desire is basically mismatched sex drives whose solution is not a drug. Secondly, they contend that the creation of this drug is an attempt to medicalize the female body (Thacker, 2014). Third, flibranserin has been opposed on the premise that its creation is for commercial purposes rather than any medical benefits. For instance, the manufacturer of flibranserin, Sprout Pharmaceuticals, recently announced that it’s being sold to Valeant for $1 billion (Watching the Hawks RT, 2015). Therefore, this drug is seen as an attempt by the manufacturer to increase its profits through aggressive marketing.

Potential Benefits and Risks

The potential benefit of flibranserin is bumping neurotransmitters to revive the flagging flames of sexual desires in a woman (Schulte, 2015). Unlike Viagra that enhances blood….....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Controversy Surrounding New Female Viagra" (2017, August 02) Retrieved June 19, 2025, from
https://www.aceyourpaper.com/essays/controversy-surrounding-new-female-viagra-2165747
   

Open, View, and/or
Download this Document
order custom essay example